Patient navigation program indicators are valuable to inform decision-making and program improvement, provide critical updates to stakeholders, and to describe program reach. The American Cancer Society (ACS) defined a comprehensive set of global patient navigation program indicators to guide program implementation data collection and reporting on an annual basis.
While there are countless measures of interest, ACS prioritized 18 indicators given their breadth in describing programs’ reach as well as their feasibility for data collection and analysis. ACS identified a subset of 3 essential indicators that all patient navigation programs in LMIC settings are encouraged to track if applicable and those receiving financial and technical support from ACS for program implementation1 are required to report. The 3 essential indicators are identified in bold type in the table. ACS recommends tracking the remaining 15 indicators but also understands the variability that exists in program designs, in the availability of specific data, as well as in programs’ capacity for collecting and analyzing data. Programs might also identify other indicators for measuring progress based on their program objectives and interests.
Handout: ACS Global Patient Navigation Indicators
Year:
2023
Languages:
English
Location:
International
Organization:
American Cancer Society (ACS)
Summary: